

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.09103088 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.09103088 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.86966606 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.86966606 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.64200807 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.46850829 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 5.42203677 |
| 8 | bile acid biosynthetic process (GO:0006699) | 5.22799467 |
| 9 | cysteine metabolic process (GO:0006534) | 5.20836710 |
| 10 | urea metabolic process (GO:0019627) | 5.06544129 |
| 11 | urea cycle (GO:0000050) | 5.06544129 |
| 12 | intestinal cholesterol absorption (GO:0030299) | 5.01824400 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.00249359 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 4.90713227 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 4.84043957 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 4.84043957 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.84043957 |
| 18 | serine family amino acid catabolic process (GO:0009071) | 4.80697232 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 4.80543148 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.77721249 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 4.75173600 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 4.71577779 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.68240892 |
| 24 | lysine catabolic process (GO:0006554) | 4.58985096 |
| 25 | lysine metabolic process (GO:0006553) | 4.58985096 |
| 26 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.56063693 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.51693119 |
| 28 | regulation of protein activation cascade (GO:2000257) | 4.48091684 |
| 29 | tryptophan metabolic process (GO:0006568) | 4.39853384 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.39643372 |
| 31 | negative regulation of sterol transport (GO:0032372) | 4.37424909 |
| 32 | negative regulation of cholesterol transport (GO:0032375) | 4.37424909 |
| 33 | regulation of apoptotic cell clearance (GO:2000425) | 4.31264696 |
| 34 | regulation of plasminogen activation (GO:0010755) | 4.29973646 |
| 35 | bile acid metabolic process (GO:0008206) | 4.27776769 |
| 36 | glycine metabolic process (GO:0006544) | 4.26329749 |
| 37 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.21918155 |
| 38 | protein carboxylation (GO:0018214) | 4.21918155 |
| 39 | glutamate metabolic process (GO:0006536) | 4.21525717 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.21421549 |
| 41 | regulation of complement activation (GO:0030449) | 4.20743407 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.18212050 |
| 43 | cellular ketone body metabolic process (GO:0046950) | 4.09397291 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.08976024 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.08516210 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.08516210 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.08516210 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.02841245 |
| 49 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.00708421 |
| 50 | serine family amino acid metabolic process (GO:0009069) | 4.00262978 |
| 51 | cellular modified amino acid catabolic process (GO:0042219) | 3.99198713 |
| 52 | regulation of humoral immune response (GO:0002920) | 3.92175560 |
| 53 | proline metabolic process (GO:0006560) | 3.91462773 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 3.91404223 |
| 55 | regulation of bile acid biosynthetic process (GO:0070857) | 3.91155897 |
| 56 | intestinal absorption (GO:0050892) | 3.89938369 |
| 57 | homocysteine metabolic process (GO:0050667) | 3.89173418 |
| 58 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.84963926 |
| 59 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.84963926 |
| 60 | positive regulation of steroid metabolic process (GO:0045940) | 3.84539245 |
| 61 | regulation of cholesterol esterification (GO:0010872) | 3.82776805 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 3.80768412 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 3.79154785 |
| 64 | regulation of cholesterol homeostasis (GO:2000188) | 3.75486656 |
| 65 | serine family amino acid biosynthetic process (GO:0009070) | 3.74939278 |
| 66 | plasma lipoprotein particle assembly (GO:0034377) | 3.74526321 |
| 67 | negative regulation of protein activation cascade (GO:2000258) | 3.74242504 |
| 68 | epoxygenase P450 pathway (GO:0019373) | 3.74162327 |
| 69 | phospholipid efflux (GO:0033700) | 3.73695146 |
| 70 | tyrosine metabolic process (GO:0006570) | 3.72167988 |
| 71 | regulation of cholesterol metabolic process (GO:0090181) | 3.67188183 |
| 72 | triglyceride homeostasis (GO:0070328) | 3.65697014 |
| 73 | acylglycerol homeostasis (GO:0055090) | 3.65697014 |
| 74 | positive regulation of lipid catabolic process (GO:0050996) | 3.65587365 |
| 75 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.65508528 |
| 76 | regulation of extracellular matrix disassembly (GO:0010715) | 3.64003251 |
| 77 | acute-phase response (GO:0006953) | 3.59372511 |
| 78 | cholesterol efflux (GO:0033344) | 3.58608267 |
| 79 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.56330698 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 3.56020911 |
| 81 | coenzyme catabolic process (GO:0009109) | 3.55839372 |
| 82 | diacylglycerol metabolic process (GO:0046339) | 3.51979495 |
| 83 | cytolysis (GO:0019835) | 3.51269674 |
| 84 | acetyl-CoA metabolic process (GO:0006084) | 3.44496180 |
| 85 | negative regulation of blood coagulation (GO:0030195) | 3.43016854 |
| 86 | negative regulation of hemostasis (GO:1900047) | 3.43016854 |
| 87 | lipoprotein metabolic process (GO:0042157) | 3.42658428 |
| 88 | ketone body metabolic process (GO:1902224) | 3.41202591 |
| 89 | ethanol oxidation (GO:0006069) | 3.39144808 |
| 90 | sterol transport (GO:0015918) | 3.38976500 |
| 91 | cholesterol transport (GO:0030301) | 3.38976500 |
| 92 | positive regulation of extracellular matrix organization (GO:1903055) | 3.38644282 |
| 93 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.35977551 |
| 94 | blood coagulation, intrinsic pathway (GO:0007597) | 3.35557221 |
| 95 | protein-lipid complex assembly (GO:0065005) | 3.34581633 |
| 96 | cholesterol homeostasis (GO:0042632) | 3.34187382 |
| 97 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.33203322 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.32449066 |
| 99 | ethanol metabolic process (GO:0006067) | 3.31681447 |
| 100 | short-chain fatty acid metabolic process (GO:0046459) | 3.30500475 |
| 101 | arginine metabolic process (GO:0006525) | 3.29573576 |
| 102 | sterol homeostasis (GO:0055092) | 3.28518443 |
| 103 | regulation of extracellular matrix organization (GO:1903053) | 3.28183116 |
| 104 | fibrinolysis (GO:0042730) | 3.27789557 |
| 105 | bile acid and bile salt transport (GO:0015721) | 3.26676229 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.26452025 |
| 107 | organic acid catabolic process (GO:0016054) | 3.24592225 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.24592225 |
| 109 | drug catabolic process (GO:0042737) | 3.20613731 |
| 110 | indolalkylamine metabolic process (GO:0006586) | 3.20235490 |
| 111 | acylglycerol catabolic process (GO:0046464) | 3.18496504 |
| 112 | neutral lipid catabolic process (GO:0046461) | 3.18496504 |
| 113 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.18006701 |
| 114 | aspartate family amino acid catabolic process (GO:0009068) | 3.16353507 |
| 115 | imidazole-containing compound metabolic process (GO:0052803) | 3.16023902 |
| 116 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.15442925 |
| 117 | phospholipid homeostasis (GO:0055091) | 3.14054430 |
| 118 | negative regulation of coagulation (GO:0050819) | 3.11267597 |
| 119 | negative regulation of complement activation (GO:0045916) | 3.11014133 |
| 120 | negative regulation of lipase activity (GO:0060192) | 3.10684156 |
| 121 | complement activation (GO:0006956) | 3.07582051 |
| 122 | cellular glucuronidation (GO:0052695) | 3.07053044 |
| 123 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.06803177 |
| 124 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.06803177 |
| 125 | complement activation, classical pathway (GO:0006958) | 3.06481236 |
| 126 | protein-lipid complex subunit organization (GO:0071825) | 3.06359903 |
| 127 | positive regulation of hemostasis (GO:1900048) | 3.06297048 |
| 128 | positive regulation of blood coagulation (GO:0030194) | 3.06297048 |
| 129 | proline biosynthetic process (GO:0006561) | 3.06189745 |
| 130 | cellular biogenic amine catabolic process (GO:0042402) | 3.05627138 |
| 131 | amine catabolic process (GO:0009310) | 3.05627138 |
| 132 | exogenous drug catabolic process (GO:0042738) | 3.02752071 |
| 133 | protein activation cascade (GO:0072376) | 3.02645494 |
| 134 | low-density lipoprotein particle remodeling (GO:0034374) | 3.00304319 |
| 135 | cofactor catabolic process (GO:0051187) | 2.99918747 |
| 136 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.93567983 |
| 137 | negative regulation of wound healing (GO:0061045) | 2.92386801 |
| 138 | lipid homeostasis (GO:0055088) | 2.90514297 |
| 139 | negative regulation of lipid transport (GO:0032369) | 2.83588703 |
| 140 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.81483338 |
| 141 | low-density lipoprotein particle clearance (GO:0034383) | 2.81070077 |
| 142 | flavonoid metabolic process (GO:0009812) | 2.80198696 |
| 143 | positive regulation of coagulation (GO:0050820) | 2.79069053 |
| 144 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.75674405 |
| 145 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.73355140 |
| 146 | glucuronate metabolic process (GO:0019585) | 2.68400739 |
| 147 | uronic acid metabolic process (GO:0006063) | 2.68400739 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.57809440 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.51221144 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.64194879 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.02771883 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.92170658 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.39485261 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.09152303 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.27048023 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.15861747 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.53458578 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.30886829 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.26531783 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.05364968 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.02540916 |
| 15 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.98711992 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.96213098 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 1.95980479 |
| 18 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.82758026 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82532630 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80235341 |
| 21 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.76748475 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76115188 |
| 23 | GATA1_19941826_ChIP-Seq_K562_Human | 1.69705516 |
| 24 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.62075462 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.54371167 |
| 26 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.53068784 |
| 27 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.52985742 |
| 28 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52321956 |
| 29 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.51318405 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.51071259 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50162635 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.48427561 |
| 33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.44103384 |
| 34 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.42759299 |
| 35 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.41784397 |
| 36 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39959544 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.39899530 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38395195 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.35115839 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34281427 |
| 41 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.34078309 |
| 42 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.33393310 |
| 43 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.32880262 |
| 44 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.32602597 |
| 45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32362790 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.32001883 |
| 47 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31932740 |
| 48 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.28881525 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28454369 |
| 50 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27284435 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.25393203 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20932830 |
| 53 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20183798 |
| 54 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.19878084 |
| 55 | GATA2_19941826_ChIP-Seq_K562_Human | 1.17845099 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15958602 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15587406 |
| 58 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14528559 |
| 59 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.09400374 |
| 60 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09064758 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07400941 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07248045 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06502011 |
| 64 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06158880 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04796539 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04756900 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04469148 |
| 68 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.04125341 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04079168 |
| 70 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03854612 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01501295 |
| 72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00519071 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99274263 |
| 74 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.99227695 |
| 75 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.98845237 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.97970139 |
| 77 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97711838 |
| 78 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96715665 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96266084 |
| 80 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96138048 |
| 81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96136411 |
| 82 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96128812 |
| 83 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.95591572 |
| 84 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95362786 |
| 85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95118091 |
| 86 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.95037526 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94879763 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 0.94673798 |
| 89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.93623620 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.92825167 |
| 91 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.92652102 |
| 92 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92647009 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92504658 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92241433 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92216564 |
| 96 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91565543 |
| 97 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.91244342 |
| 98 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.90999230 |
| 99 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89586018 |
| 100 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89558093 |
| 101 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89548679 |
| 102 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88958788 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.88913315 |
| 104 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.88043666 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.87888757 |
| 106 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86885998 |
| 107 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.86885311 |
| 108 | * P68_20966046_ChIP-Seq_HELA_Human | 0.86846545 |
| 109 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86257172 |
| 110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.85885694 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.84708180 |
| 112 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.83148690 |
| 113 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80234730 |
| 114 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.79858105 |
| 115 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.79837319 |
| 116 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.79611009 |
| 117 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.79114126 |
| 118 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.78627530 |
| 119 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.77007215 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.76889290 |
| 121 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.76424763 |
| 122 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75985810 |
| 123 | SA1_27219007_Chip-Seq_Bcells_Human | 0.75901370 |
| 124 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.75743753 |
| 125 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.75377064 |
| 126 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.75366957 |
| 127 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.74785253 |
| 128 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.74641306 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.73740220 |
| 130 | MAF_26560356_Chip-Seq_TH2_Human | 0.72608276 |
| 131 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.72271298 |
| 132 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.69691603 |
| 133 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.69077868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.99178626 |
| 2 | MP0005360_urolithiasis | 6.48758344 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.20689649 |
| 4 | MP0005365_abnormal_bile_salt | 4.91098174 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.00884777 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.25685835 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.22270506 |
| 8 | MP0009840_abnormal_foam_cell | 3.03263170 |
| 9 | MP0003252_abnormal_bile_duct | 2.86317757 |
| 10 | MP0005083_abnormal_biliary_tract | 2.83513988 |
| 11 | MP0003656_abnormal_erythrocyte_physiolo | 2.67554517 |
| 12 | MP0005332_abnormal_amino_acid | 2.51639769 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.43634214 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.22354253 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.18646721 |
| 16 | MP0002822_catalepsy | 2.05466877 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.03475082 |
| 18 | MP0000609_abnormal_liver_physiology | 2.02285575 |
| 19 | MP0010368_abnormal_lymphatic_system | 1.99980513 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.83596905 |
| 21 | MP0001666_abnormal_nutrient_absorption | 1.82755761 |
| 22 | MP0003329_amyloid_beta_deposits | 1.80754260 |
| 23 | MP0003195_calcinosis | 1.77280372 |
| 24 | MP0000604_amyloidosis | 1.72522151 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.65965475 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64733675 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.60008773 |
| 28 | MP0002089_abnormal_postnatal_growth/wei | 1.57326279 |
| 29 | MP0003635_abnormal_synaptic_transmissio | 1.57148413 |
| 30 | MP0005409_darkened_coat_color | 1.57126790 |
| 31 | MP0003122_maternal_imprinting | 1.50872023 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.49500102 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.48407748 |
| 34 | MP0004019_abnormal_vitamin_homeostasis | 1.47183139 |
| 35 | MP0002736_abnormal_nociception_after | 1.44726563 |
| 36 | MP0001661_extended_life_span | 1.42462939 |
| 37 | MP0008872_abnormal_physiological_respon | 1.41074369 |
| 38 | MP0000685_abnormal_immune_system | 1.38498271 |
| 39 | MP0005451_abnormal_body_composition | 1.37945012 |
| 40 | MP0001915_intracranial_hemorrhage | 1.33033163 |
| 41 | MP0005167_abnormal_blood-brain_barrier | 1.29299521 |
| 42 | MP0004130_abnormal_muscle_cell | 1.29027986 |
| 43 | MP0003075_altered_response_to | 1.25059705 |
| 44 | MP0009745_abnormal_behavioral_response | 1.24956373 |
| 45 | MP0003868_abnormal_feces_composition | 1.23978513 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.23252133 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.22550602 |
| 48 | MP0008874_decreased_physiological_sensi | 1.20644208 |
| 49 | MP0003880_abnormal_central_pattern | 1.20188371 |
| 50 | MP0001764_abnormal_homeostasis | 1.18852850 |
| 51 | MP0000566_synostosis | 1.18695209 |
| 52 | MP0005535_abnormal_body_temperature | 1.17461437 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.15507977 |
| 54 | MP0002064_seizures | 1.14152667 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.13807272 |
| 56 | MP0003123_paternal_imprinting | 1.13471403 |
| 57 | MP0001873_stomach_inflammation | 1.12472124 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.11575503 |
| 59 | MP0000598_abnormal_liver_morphology | 1.09844010 |
| 60 | MP0005408_hypopigmentation | 1.09594280 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.07972274 |
| 62 | MP0001348_abnormal_lacrimal_gland | 1.07528255 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.03336124 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.03218127 |
| 65 | MP0000003_abnormal_adipose_tissue | 1.01438342 |
| 66 | MP0003303_peritoneal_inflammation | 1.00884665 |
| 67 | MP0008961_abnormal_basal_metabolism | 0.99766702 |
| 68 | MP0003300_gastrointestinal_ulcer | 0.98838749 |
| 69 | MP0004147_increased_porphyrin_level | 0.96846288 |
| 70 | MP0003879_abnormal_hair_cell | 0.96702460 |
| 71 | MP0005166_decreased_susceptibility_to | 0.96407835 |
| 72 | MP0005058_abnormal_lysosome_morphology | 0.94309775 |
| 73 | MP0003436_decreased_susceptibility_to | 0.92868236 |
| 74 | MP0002909_abnormal_adrenal_gland | 0.90335928 |
| 75 | MP0001529_abnormal_vocalization | 0.90059259 |
| 76 | MP0003690_abnormal_glial_cell | 0.89760025 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 0.89622130 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 0.89393706 |
| 79 | MP0002572_abnormal_emotion/affect_behav | 0.84644511 |
| 80 | MP0004264_abnormal_extraembryonic_tissu | 0.84454145 |
| 81 | MP0009642_abnormal_blood_homeostasis | 0.83370373 |
| 82 | MP0002733_abnormal_thermal_nociception | 0.83340503 |
| 83 | MP0002876_abnormal_thyroid_physiology | 0.82948798 |
| 84 | MP0005334_abnormal_fat_pad | 0.82722190 |
| 85 | MP0003866_abnormal_defecation | 0.81474258 |
| 86 | MP0008469_abnormal_protein_level | 0.79829798 |
| 87 | MP0005076_abnormal_cell_differentiation | 0.79258158 |
| 88 | MP0009115_abnormal_fat_cell | 0.78469810 |
| 89 | MP0009763_increased_sensitivity_to | 0.77809882 |
| 90 | MP0002971_abnormal_brown_adipose | 0.76437041 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.76371270 |
| 92 | MP0009765_abnormal_xenobiotic_induced | 0.76013039 |
| 93 | MP0002254_reproductive_system_inflammat | 0.75645458 |
| 94 | MP0003566_abnormal_cell_adhesion | 0.75459940 |
| 95 | MP0001756_abnormal_urination | 0.75276146 |
| 96 | MP0006035_abnormal_mitochondrial_morpho | 0.74852022 |
| 97 | MP0003953_abnormal_hormone_level | 0.74578678 |
| 98 | MP0001440_abnormal_grooming_behavior | 0.74006737 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.73707699 |
| 100 | MP0009764_decreased_sensitivity_to | 0.73300254 |
| 101 | MP0004782_abnormal_surfactant_physiolog | 0.73021503 |
| 102 | MP0005647_abnormal_sex_gland | 0.72112103 |
| 103 | MP0002933_joint_inflammation | 0.72042732 |
| 104 | MP0010155_abnormal_intestine_physiology | 0.71872116 |
| 105 | MP0003186_abnormal_redox_activity | 0.69238766 |
| 106 | MP0005375_adipose_tissue_phenotype | 0.68980170 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.68278889 |
| 108 | MP0000920_abnormal_myelination | 0.68038312 |
| 109 | MP0005670_abnormal_white_adipose | 0.67836539 |
| 110 | MP0003633_abnormal_nervous_system | 0.67410980 |
| 111 | MP0000249_abnormal_blood_vessel | 0.67262191 |
| 112 | MP0004043_abnormal_pH_regulation | 0.67245404 |
| 113 | MP0002970_abnormal_white_adipose | 0.64882684 |
| 114 | MP0001790_abnormal_immune_system | 0.64181277 |
| 115 | MP0005387_immune_system_phenotype | 0.64181277 |
| 116 | MP0001944_abnormal_pancreas_morphology | 0.63937378 |
| 117 | MP0005023_abnormal_wound_healing | 0.61294469 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.60379903 |
| 119 | MP0003950_abnormal_plasma_membrane | 0.60187330 |
| 120 | MP0002272_abnormal_nervous_system | 0.59894570 |
| 121 | MP0008569_lethality_at_weaning | 0.59238907 |
| 122 | MP0002132_abnormal_respiratory_system | 0.59204623 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.59058031 |
| 124 | MP0005395_other_phenotype | 0.58914820 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.58280206 |
| 126 | MP0005448_abnormal_energy_balance | 0.58176621 |
| 127 | MP0003172_abnormal_lysosome_physiology | 0.57981420 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.57835336 |
| 129 | MP0002006_tumorigenesis | 0.57079761 |
| 130 | MP0002168_other_aberrant_phenotype | 0.56948711 |
| 131 | MP0002136_abnormal_kidney_physiology | 0.56487992 |
| 132 | MP0008873_increased_physiological_sensi | 0.55672459 |
| 133 | MP0005376_homeostasis/metabolism_phenot | 0.55513587 |
| 134 | MP0005379_endocrine/exocrine_gland_phen | 0.55202461 |
| 135 | MP0005025_abnormal_response_to | 0.54881702 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.54716134 |
| 137 | MP0005397_hematopoietic_system_phenotyp | 0.54556450 |
| 138 | MP0001545_abnormal_hematopoietic_system | 0.54556450 |
| 139 | MP0009046_muscle_twitch | 0.54171769 |
| 140 | MP0004924_abnormal_behavior | 0.53832151 |
| 141 | MP0005386_behavior/neurological_phenoty | 0.53832151 |
| 142 | MP0004270_analgesia | 0.53777250 |
| 143 | MP0001970_abnormal_pain_threshold | 0.53730183 |
| 144 | MP0004811_abnormal_neuron_physiology | 0.52227081 |
| 145 | MP0002067_abnormal_sensory_capabilities | 0.52200309 |
| 146 | MP0004858_abnormal_nervous_system | 0.52039789 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.21787013 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.77841890 |
| 3 | Xanthomatosis (HP:0000991) | 5.39652527 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.09754383 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.72713378 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.62404992 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 4.53699950 |
| 8 | Hemorrhage of the eye (HP:0011885) | 4.51419833 |
| 9 | Complement deficiency (HP:0004431) | 4.42532438 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 4.37225483 |
| 11 | Hyperglycinemia (HP:0002154) | 4.06622416 |
| 12 | Hyperammonemia (HP:0001987) | 3.70087829 |
| 13 | Hyperglycinuria (HP:0003108) | 3.63112476 |
| 14 | Joint hemorrhage (HP:0005261) | 3.60717131 |
| 15 | Poikilocytosis (HP:0004447) | 3.57389896 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.55891745 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.55891745 |
| 18 | Ketosis (HP:0001946) | 3.54580660 |
| 19 | Abnormality of complement system (HP:0005339) | 3.53540493 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.45690920 |
| 21 | Epidermoid cyst (HP:0200040) | 3.44012057 |
| 22 | Acanthocytosis (HP:0001927) | 3.40719846 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.38033571 |
| 24 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.29386101 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.19362408 |
| 26 | Hyperbilirubinemia (HP:0002904) | 3.19324712 |
| 27 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.19111656 |
| 28 | Reticulocytosis (HP:0001923) | 3.15060065 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.08601929 |
| 30 | Myokymia (HP:0002411) | 3.07973882 |
| 31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.07266181 |
| 32 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.05706058 |
| 33 | Vascular calcification (HP:0004934) | 3.00846773 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 2.99756840 |
| 35 | Neonatal onset (HP:0003623) | 2.87198784 |
| 36 | Cholelithiasis (HP:0001081) | 2.84610544 |
| 37 | Status epilepticus (HP:0002133) | 2.80319366 |
| 38 | Purpura (HP:0000979) | 2.79262989 |
| 39 | Gingival bleeding (HP:0000225) | 2.76750653 |
| 40 | Global brain atrophy (HP:0002283) | 2.75886068 |
| 41 | Flat acetabular roof (HP:0003180) | 2.75413770 |
| 42 | Hypercholesterolemia (HP:0003124) | 2.73197674 |
| 43 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.70211625 |
| 44 | Nephritis (HP:0000123) | 2.69374512 |
| 45 | Abnormal gallbladder physiology (HP:0012438) | 2.69183900 |
| 46 | Cholecystitis (HP:0001082) | 2.69183900 |
| 47 | Gout (HP:0001997) | 2.66753174 |
| 48 | Abnormality of the lower motor neuron (HP:0002366) | 2.66546628 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 2.63691870 |
| 50 | Abnormality of carpal bone ossification (HP:0006257) | 2.63118167 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.62657287 |
| 52 | Abnormality of serum amino acid levels (HP:0003112) | 2.62469131 |
| 53 | Hypochromic microcytic anemia (HP:0004840) | 2.61571624 |
| 54 | Abnormal gallbladder morphology (HP:0012437) | 2.60883458 |
| 55 | Cardiovascular calcification (HP:0011915) | 2.57338082 |
| 56 | Spontaneous abortion (HP:0005268) | 2.56529825 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.53054942 |
| 58 | Pigmentary retinal degeneration (HP:0001146) | 2.52726895 |
| 59 | Fat malabsorption (HP:0002630) | 2.49514331 |
| 60 | Myocardial infarction (HP:0001658) | 2.48999581 |
| 61 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.47942598 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.43547564 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.43433618 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.42164273 |
| 65 | Skin nodule (HP:0200036) | 2.41005922 |
| 66 | Mitral stenosis (HP:0001718) | 2.35947615 |
| 67 | Ketoacidosis (HP:0001993) | 2.33759787 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.33515696 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 2.30844755 |
| 70 | Metabolic acidosis (HP:0001942) | 2.30039808 |
| 71 | Abnormal tarsal ossification (HP:0008369) | 2.28460912 |
| 72 | Irritability (HP:0000737) | 2.28221557 |
| 73 | Hepatocellular carcinoma (HP:0001402) | 2.27983175 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.23661037 |
| 75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.23661037 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.16911385 |
| 77 | Asymmetry of the thorax (HP:0001555) | 2.11617290 |
| 78 | Amyloidosis (HP:0011034) | 2.11063131 |
| 79 | Impaired social interactions (HP:0000735) | 2.10773974 |
| 80 | Abnormal social behavior (HP:0012433) | 2.10773974 |
| 81 | Rickets (HP:0002748) | 2.10404496 |
| 82 | Thrombophlebitis (HP:0004418) | 2.09976751 |
| 83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08894212 |
| 84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08894212 |
| 85 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08894212 |
| 86 | Abnormal ossification of hand bones (HP:0005921) | 2.07041281 |
| 87 | Neonatal death (HP:0003811) | 2.06703617 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 2.06552867 |
| 89 | Spastic diplegia (HP:0001264) | 2.06190039 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 2.05217796 |
| 91 | Lethargy (HP:0001254) | 2.04507250 |
| 92 | Hypophosphatemic rickets (HP:0004912) | 2.02749305 |
| 93 | Abnormality of the gallbladder (HP:0005264) | 2.02688062 |
| 94 | Cerebral inclusion bodies (HP:0100314) | 2.01483781 |
| 95 | Polycythemia (HP:0001901) | 1.98837456 |
| 96 | Focal motor seizures (HP:0011153) | 1.98549316 |
| 97 | Abnormal hand bone ossification (HP:0010660) | 1.98192330 |
| 98 | Pulmonary embolism (HP:0002204) | 1.97185984 |
| 99 | Joint swelling (HP:0001386) | 1.95516849 |
| 100 | Hyperventilation (HP:0002883) | 1.94761274 |
| 101 | Fair hair (HP:0002286) | 1.94226928 |
| 102 | Torticollis (HP:0000473) | 1.93722732 |
| 103 | Hypertriglyceridemia (HP:0002155) | 1.93093755 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92404465 |
| 105 | Glomerulonephritis (HP:0000099) | 1.91009854 |
| 106 | Visual hallucinations (HP:0002367) | 1.90952770 |
| 107 | Steatorrhea (HP:0002570) | 1.89726054 |
| 108 | Craniofacial dystonia (HP:0012179) | 1.88786463 |
| 109 | Vomiting (HP:0002013) | 1.87725283 |
| 110 | Increased serum ferritin (HP:0003281) | 1.87430064 |
| 111 | Conjugated hyperbilirubinemia (HP:0002908) | 1.86962157 |
| 112 | Increased mean platelet volume (HP:0011877) | 1.86915768 |
| 113 | Focal dystonia (HP:0004373) | 1.86470738 |
| 114 | Epistaxis (HP:0000421) | 1.86378652 |
| 115 | Abnormality of proline metabolism (HP:0010907) | 1.83766293 |
| 116 | Hydroxyprolinuria (HP:0003080) | 1.83766293 |
| 117 | Gastrointestinal infarctions (HP:0005244) | 1.83068553 |
| 118 | Poor eye contact (HP:0000817) | 1.83016632 |
| 119 | Menorrhagia (HP:0000132) | 1.82756905 |
| 120 | Dysmetric saccades (HP:0000641) | 1.82455957 |
| 121 | Limb hypertonia (HP:0002509) | 1.81933072 |
| 122 | Hypoplasia of the thymus (HP:0000778) | 1.81722656 |
| 123 | Focal seizures (HP:0007359) | 1.80632516 |
| 124 | Late onset (HP:0003584) | 1.80410327 |
| 125 | Achilles tendon contracture (HP:0001771) | 1.80124455 |
| 126 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.78739989 |
| 127 | Dicarboxylic aciduria (HP:0003215) | 1.78739989 |
| 128 | Axonal loss (HP:0003447) | 1.78579512 |
| 129 | Abnormal platelet volume (HP:0011876) | 1.77583262 |
| 130 | Osteomalacia (HP:0002749) | 1.75837072 |
| 131 | Hypochromic anemia (HP:0001931) | 1.70995355 |
| 132 | Dysostosis multiplex (HP:0000943) | 1.70585375 |
| 133 | Potter facies (HP:0002009) | 1.69118234 |
| 134 | Facial shape deformation (HP:0011334) | 1.69118234 |
| 135 | Esophageal varix (HP:0002040) | 1.68732268 |
| 136 | Cerebral aneurysm (HP:0004944) | 1.67119284 |
| 137 | Widely patent fontanelles and sutures (HP:0004492) | 1.66565601 |
| 138 | Testicular neoplasm (HP:0010788) | 1.62468293 |
| 139 | Ileus (HP:0002595) | 1.60120869 |
| 140 | Hypotension (HP:0002615) | 1.59931850 |
| 141 | Lymphangioma (HP:0100764) | 1.58607234 |
| 142 | Vertebral compression fractures (HP:0002953) | 1.57874653 |
| 143 | Hypophosphatemia (HP:0002148) | 1.57714514 |
| 144 | Abnormal foot bone ossification (HP:0010675) | 1.55167229 |
| 145 | Bronchomalacia (HP:0002780) | 1.54710288 |
| 146 | Seborrheic dermatitis (HP:0001051) | 1.53846724 |
| 147 | Vaginal fistula (HP:0004320) | 1.52122963 |
| 148 | Generalized aminoaciduria (HP:0002909) | 1.51611920 |
| 149 | Flared iliac wings (HP:0002869) | 1.51014617 |
| 150 | Abnormality of the nasal septum (HP:0000419) | 1.49463559 |
| 151 | Prolonged bleeding time (HP:0003010) | 1.49268504 |
| 152 | Visceral angiomatosis (HP:0100761) | 1.48860446 |
| 153 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.47887022 |
| 154 | Small epiphyses (HP:0010585) | 1.46580653 |
| 155 | Abnormal platelet function (HP:0011869) | 1.45999249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 3.97315711 |
| 2 | NTRK3 | 3.42344368 |
| 3 | ICK | 3.12544141 |
| 4 | TRIB3 | 3.11319075 |
| 5 | BCKDK | 3.02103920 |
| 6 | CDK12 | 2.90084457 |
| 7 | RIPK4 | 2.78746311 |
| 8 | PKN2 | 2.75333903 |
| 9 | DAPK2 | 2.66427110 |
| 10 | GRK6 | 2.58035789 |
| 11 | KSR2 | 2.46539392 |
| 12 | MAP3K9 | 2.46104753 |
| 13 | ERN1 | 2.32847143 |
| 14 | SMG1 | 2.30376379 |
| 15 | DAPK1 | 2.12020358 |
| 16 | FGFR4 | 2.07291004 |
| 17 | SIK1 | 2.06029121 |
| 18 | MINK1 | 2.04916686 |
| 19 | PRKD3 | 1.88495618 |
| 20 | MAP2K4 | 1.86503083 |
| 21 | KSR1 | 1.80806615 |
| 22 | SIK2 | 1.69163028 |
| 23 | NTRK1 | 1.59796347 |
| 24 | EPHA2 | 1.59712976 |
| 25 | CAMKK1 | 1.57257573 |
| 26 | FES | 1.51803094 |
| 27 | MAPK11 | 1.47471644 |
| 28 | FGFR2 | 1.45958013 |
| 29 | MAP4K1 | 1.44414344 |
| 30 | MAP3K10 | 1.42644852 |
| 31 | IRAK3 | 1.42268173 |
| 32 | MST1R | 1.31727627 |
| 33 | WNK4 | 1.29790291 |
| 34 | TAOK1 | 1.28570331 |
| 35 | NEK1 | 1.22434513 |
| 36 | PRKAA2 | 1.18828977 |
| 37 | PTK2B | 1.18701602 |
| 38 | MAPKAPK3 | 1.17446518 |
| 39 | RAF1 | 1.15313517 |
| 40 | PDK1 | 1.13909946 |
| 41 | BRSK1 | 1.13389564 |
| 42 | MAP3K4 | 1.12880205 |
| 43 | MAP3K13 | 1.12344490 |
| 44 | PAK6 | 1.10865521 |
| 45 | ARAF | 1.10347635 |
| 46 | WNK1 | 1.08046646 |
| 47 | RIPK1 | 1.06083474 |
| 48 | MARK2 | 1.04743877 |
| 49 | CDC42BPA | 1.04289153 |
| 50 | SGK3 | 1.03579547 |
| 51 | MAP3K12 | 1.02956762 |
| 52 | EEF2K | 1.02288825 |
| 53 | FGR | 0.99410124 |
| 54 | MAP2K3 | 0.99294152 |
| 55 | PDPK1 | 0.98920116 |
| 56 | TAOK3 | 0.98858903 |
| 57 | PIK3CA | 0.95048281 |
| 58 | PTK6 | 0.93388171 |
| 59 | RET | 0.93266564 |
| 60 | SYK | 0.93201789 |
| 61 | AKT3 | 0.93123930 |
| 62 | GRK5 | 0.93085181 |
| 63 | TNK2 | 0.92552048 |
| 64 | PRPF4B | 0.92537864 |
| 65 | MAP3K3 | 0.92420600 |
| 66 | STK38 | 0.91847180 |
| 67 | EPHB1 | 0.91746337 |
| 68 | JAK2 | 0.91671815 |
| 69 | MAP3K7 | 0.90171120 |
| 70 | PDGFRA | 0.88671029 |
| 71 | TYK2 | 0.87802596 |
| 72 | CAMK1D | 0.85694220 |
| 73 | CDK4 | 0.83121543 |
| 74 | PRKD2 | 0.82022961 |
| 75 | PRKCG | 0.80677086 |
| 76 | TAOK2 | 0.80600118 |
| 77 | NTRK2 | 0.80036380 |
| 78 | PRKG2 | 0.79448083 |
| 79 | KDR | 0.78856581 |
| 80 | ITK | 0.75674826 |
| 81 | MTOR | 0.75596658 |
| 82 | CDK5 | 0.73836906 |
| 83 | MAP2K6 | 0.73373773 |
| 84 | ABL2 | 0.73032344 |
| 85 | CSK | 0.72956313 |
| 86 | SIK3 | 0.66558195 |
| 87 | LMTK2 | 0.66163601 |
| 88 | IKBKE | 0.66155996 |
| 89 | FGFR1 | 0.65884270 |
| 90 | MAP3K11 | 0.65731082 |
| 91 | FLT3 | 0.64384333 |
| 92 | CDC7 | 0.63250957 |
| 93 | MAP2K7 | 0.62247938 |
| 94 | CDK18 | 0.62098240 |
| 95 | MAP2K1 | 0.60980573 |
| 96 | PRKCH | 0.60841869 |
| 97 | MELK | 0.60355393 |
| 98 | CDK15 | 0.60037642 |
| 99 | MAP3K1 | 0.60035200 |
| 100 | LATS2 | 0.59724613 |
| 101 | MAPK12 | 0.59642586 |
| 102 | MAP3K6 | 0.59007755 |
| 103 | DDR2 | 0.58148110 |
| 104 | HIPK2 | 0.57257855 |
| 105 | MET | 0.56642581 |
| 106 | MAP3K2 | 0.56581562 |
| 107 | TIE1 | 0.56362202 |
| 108 | FER | 0.56321577 |
| 109 | JAK1 | 0.55540811 |
| 110 | MAPK4 | 0.53913529 |
| 111 | CDK11A | 0.53842063 |
| 112 | SGK2 | 0.53436808 |
| 113 | PRKAA1 | 0.53383653 |
| 114 | PINK1 | 0.51999312 |
| 115 | BMX | 0.51903471 |
| 116 | SGK494 | 0.50559448 |
| 117 | SGK223 | 0.50559448 |
| 118 | CDK14 | 0.48152021 |
| 119 | PRKACG | 0.48094347 |
| 120 | FGFR3 | 0.46828671 |
| 121 | ZAP70 | 0.46190003 |
| 122 | PDK4 | 0.46022781 |
| 123 | PDK3 | 0.46022781 |
| 124 | BLK | 0.45514850 |
| 125 | SGK1 | 0.43881370 |
| 126 | PTK2 | 0.43778748 |
| 127 | NEK9 | 0.42555974 |
| 128 | CDK7 | 0.42389088 |
| 129 | TRPM7 | 0.40486355 |
| 130 | TYRO3 | 0.40355247 |
| 131 | CSF1R | 0.40243143 |
| 132 | STK11 | 0.39803284 |
| 133 | CDK9 | 0.39281542 |
| 134 | DYRK1B | 0.39092185 |
| 135 | PRKCZ | 0.38952987 |
| 136 | UHMK1 | 0.38688936 |
| 137 | CAMK1 | 0.38581963 |
| 138 | DAPK3 | 0.37865962 |
| 139 | LRRK2 | 0.37653959 |
| 140 | ERBB2 | 0.37428167 |
| 141 | TBK1 | 0.36962430 |
| 142 | FYN | 0.36754787 |
| 143 | PRKCQ | 0.36275983 |
| 144 | HCK | 0.36070392 |
| 145 | MAP3K8 | 0.35485605 |
| 146 | MAP3K14 | 0.34661168 |
| 147 | TGFBR2 | 0.34624154 |
| 148 | STK39 | 0.33741472 |
| 149 | IRAK4 | 0.33264278 |
| 150 | PRKCI | 0.32554643 |
| 151 | MAP2K2 | 0.32105151 |
| 152 | CAMK1G | 0.31177567 |
| 153 | SRC | 0.29852514 |
| 154 | MAPK3 | 0.28856225 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.63065968 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.13020837 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.68858886 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.29379602 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.97473046 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.90666982 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.47847115 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39331913 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.34733636 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22852865 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20217864 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11672519 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.09246476 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.03669659 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.97492516 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.95234526 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.88541738 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.84538264 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.80278780 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.80012668 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74223198 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.72894761 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68276801 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61756643 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61074062 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59609589 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.53387132 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48323130 |
| 29 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47165311 |
| 30 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.44629594 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43896735 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39399399 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.37624462 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36524947 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31791836 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.30042017 |
| 37 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.24218033 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.19291220 |
| 39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17748088 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.14129107 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11267219 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06027846 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.03165951 |
| 44 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99682883 |
| 45 | Sulfur relay system_Homo sapiens_hsa04122 | 0.96543282 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95835690 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95300837 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.95241625 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91134730 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.86861757 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.84737280 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82543625 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.80692582 |
| 54 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75052332 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74081447 |
| 56 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72711324 |
| 57 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71879937 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71216021 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.70783838 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70584457 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69302838 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64381448 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62114974 |
| 64 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61685135 |
| 65 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61679504 |
| 66 | Nicotine addiction_Homo sapiens_hsa05033 | 0.61592992 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.60823150 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60487784 |
| 69 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.52662249 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 0.49757758 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.49753244 |
| 72 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.49736895 |
| 73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49634800 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48008930 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44790440 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43442722 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.43246652 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43137738 |
| 79 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42023407 |
| 80 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41394886 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.41280298 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41272496 |
| 83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.40844115 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40792801 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39558607 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38664278 |
| 87 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.37236251 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.37136377 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.36841015 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36530824 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34805784 |
| 92 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.34456344 |
| 93 | GABAergic synapse_Homo sapiens_hsa04727 | 0.34032392 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33530421 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32893845 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32705320 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31925154 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31668518 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.31302225 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31129039 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.30917320 |
| 102 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.30893535 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.30039427 |
| 104 | Circadian entrainment_Homo sapiens_hsa04713 | 0.27472181 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.27315170 |
| 106 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.26542544 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26521605 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.25203159 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.24758170 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.23509763 |
| 111 | Metabolic pathways_Homo sapiens_hsa01100 | 0.21415007 |
| 112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.21397517 |
| 113 | Renin secretion_Homo sapiens_hsa04924 | 0.21348930 |
| 114 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.20499077 |
| 115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18573968 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.18214226 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.18086008 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18066542 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17931706 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.17687583 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.17646876 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.17597017 |
| 123 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.17380558 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.16836324 |
| 125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.16750313 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.16341357 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.16106772 |
| 128 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.15466053 |
| 129 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14967174 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13900986 |

